Jan 22 (Reuters) - EUREKA THERAPEUTICS:
* EUREKA THERAPEUTICS CLOSES $60 MILLION IN SERIES D FINANCING TO ADVANCE PROPRIETARY ARTEMIS™ T CELL RECEPTOR PLATFORM FOR SAFER T CELL THERAPIES
* EUREKA THERAPEUTICS - ACORN PACIFIC VENTURES LED ROUND, WITH PARTICIPATION FROM GP CAPITAL AND ALL EXISTING MAJOR INVESTORS Source text for Eikon:
Our Standards: The Thomson Reuters Trust Principles.